← Eichor
Study identifier: NCT05331664 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Dropless Pars Plana Vitrectomy Study

Condition: Rhegmatogenous Retinal Detachment  ·  Sponsor: Massachusetts Eye and Ear Infirmary

PhasePhase 4
Planned participants168
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersYes

About this study

To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.

This description comes directly from the study's public registry record.

Talk to the study team

Nimesh A. Patel, MD  ·  617-523-7900  ·  nimesh_patel2@meei.harvard.edu

Sandra Alhoyek, MD  ·  617-523-7900  ·  salhoyek@meei.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Massachusetts Eye and EarBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05331664